School of Medicine
Showing 6,601-6,650 of 13,018 Results
-
Babak Litkouhi
Clinical Associate Professor, Obstetrics & Gynecology - Gynecologic Oncology
BioDr. Litkouhi joined the Stanford Women's Cancer Center in 2019. He was previously faculty at Yale and Harvard universities, and co-chief of gynecologic oncology at John Theurer Cancer Center in NJ. His expertise is in gynecologic cancer surgery and chemotherapeutic management of gynecologic cancers, including HIPEC. He has expertise in open, laparoscopic, and robotic radical surgery. He is the director of the gynecologic oncology fellowship program at Stanford. He has been the recipient of numerous patient-care and teaching awards, and is an active researcher and clinical trialist.
-
Iris Litt
Marron and Mary Elizabeth Kendrick Professor in Pediatrics, Emerita
Current Research and Scholarly InterestsResearch focus is on the health problems of adolescent women, with particular emphasis on the interaction of psychosocial phenomena with biologic features of the second decade of life. The effects of eating disorders on reproductive physiology, bone density and growth is one example of this interest. Pregnancy prevention and medication compliance in adolescents are other research interests.
-
Jonathan Samuel Litt
Associate Professor of Pediatrics (Neonatal and Developmental Medicine) and, by courtesy, of Epidemiology and Population Health
Current Research and Scholarly InterestsMy research program has two distinct though closely related areas of focus. The first concerns understanding pathways through which chronic health problems impact behavioral development and functional outcomes among preterm infants. I am particularly interested in how neonatal multimorbidity and associated markers of epigenetic aging can help improve risk-prediction for long-term functional outcomes. My second area of academic focus is bringing health services research and improvement science approaches to studying the delivery of high-risk infant follow-up and developing innovative models of post-discharge care. This work includes a focus on population health management, value-based care, and equity-focused quality improvement.
-
Anne Liu
Clinical Professor, Pediatrics - Immunology
Clinical Associate Professor (By courtesy), Medicine - Pulmonary, Allergy & Critical Care MedicineBioDr. Liu is a board-certified, fellowship-trained specialist in allergy/immunology and infectious disease. She is also a clinical associate professor in the Department of Medicine, Division of Infectious Diseases and the Department of Pediatrics, Division of Allergy, Immunology, and Rheumatology at Stanford University School of Medicine.
Dr. Liu treats infections in patients with compromised immune systems, whether due to a primary immune deficiency or a condition like cancer or organ transplant. She helps patients to develop tolerance to medications they are allergic to so that they can receive the best, and sometimes the only, treatments available to them. She also treats allergies to antibiotics, aspirin, NSAIDs, chemotherapy, and more. She sees patients both long term and for urgent referrals, such as in cases of perioperative anaphylaxis. Dr. Liu also helps pediatric patients manage drug and food allergies.
One of Dr. Liu’s areas of focus is helping patients with allergies to antibiotics determine when they have lost an allergy, what antibiotics they can tolerate, and when to induce tolerance to an antibiotic. This not only can benefit the patient, but also have a positive public health impact, as labeling patients with a penicillin allergy may negatively affect their care and increase use
of broad-spectrum antibiotics.
She collaborates closely with colleagues from other disciplines, including pulmonology, otolaryngology, oncology, cardiology, dermatology, anesthesiology, and surgery. Her key objective in working with referring physicians is to help them safely deliver the best care for their patients.
For patients and families, Dr. Liu strives to help them navigate their care journey with as much ease and dignity as possible during what may be the most challenging time of their life. Her goal is to offer patients options, even when it may appear that they have no options left.
Dr. Liu’s research interests include optimizing care of patients with antibiotic allergies, including through use of decision support tools.
Dr. Liu has authored articles in the New England Journal of Medicine, Journal of Immunology, Journal of Allergy and Clinical Immunology in Practice, Clinical and Experimental Allergy, Mucosal Immunology, Diagnostic Microbiology and Infectious Disease, Science, and other publications. Dr. Liu authored the book chapter “Hypersensitivity Reactions to Monoclonal Antibodies” in Drug Allergy Testing.
Dr. Liu is certified in infectious disease by the American Board of Internal Medicine and in allergy and immunology by the American Board of Allergy and Immunology. She is also a member of the American College of Physicians, Infectious Diseases Society of America, and American Academy of Allergy, Asthma, and Immunology.
She has given presentations on antibiotic allergies, drug desensitization, and aspirin-exacerbated respiratory disease, among other topics. Dr. Liu’s honors include recognition from the American Academy of Asthma, Allergy, and Immunology, the American Medical Women’s Association, and the National Institutes of Health. -
Christine Kee Liu
Associate Professor of Medicine (Primary Care and Population Health)
BioDr. Liu and her research program are dedicated to improving the lives of older adults with kidney disease. Currently her research focuses on mobility, which is the ability to move safely and reliably from one place to another. In older adults, poor mobility strongly predicts future disability and death. Retaining mobility has been cited by older adults as fundamental to quality to life; yet many older persons with kidney disease, especially those with late stage chronic kidney disease or outright kidney failure, have trouble just walking across the room or transferring to a chair. Dually trained in geriatric medicine and epidemiology, Dr. Liu also has significant expertise in older adult clinical trials, including safety trials of novel agents as well as intervention studies to reduce infections in older populations.
-
Daniel Dan Liu
Resident in Pathology
BioDaniel received his bachelor's degree in Molecular Biology from Princeton University in 2018, where he conducted research under Dr. Yibin Kang on cancer metastasis and cancer stem cell biology. He then came to Stanford for his MD-PhD training, where he joined the laboratory of Dr. Irv Weissman. His graduate research concerned the prospective isolation of neural stem cells from primary human brain tissue, in development and across lifespan.
Daniel is currently a resident in Anatomic and Neuropathology at Stanford Medicine. -
Jonathan T.C. Liu, PhD
Professor of Pathology and Professor, by courtesy, of Bioengineering
Current Research and Scholarly InterestsBiomedical optics
In vivo microscopy
Slide-free pathology
Three-dimensional microscopy
3D pathology
Optical biopsy
Image-guided surgery
Early detection
Artificial intelligence
Machine learning
Deep learning
Computational analysis
Computational pathology
Virtual staining
Molecular imaging -
Juliana Liu, MSN, RN, ANP-C
Affiliate, CVI/Vera Moulton Wall Center
BioJuliana Liu, MSN, RN, ANP-C is the Program Manager and Nurse Practitioner for the Adult Pulmonary Hypertension Service at Stanford. She received her Adult Nurse Practitioner (ANP) degree from the University of California, San Francisco School of Nursing. She has a BA in History from Pomona College. Juliana Liu has worked in the Pulmonary Hypertension field since 2002, and has presented at numerous nursing and patient conferences in the US and abroad. She has also served as member and chair on several committees of the Pulmonary Hypertension Association.
-
Katherine Liu
MD Student, expected graduation Spring 2029
MSTP StudentCurrent Research and Scholarly InterestsSignal and image processing of neural dynamics under various brain states
-
Lili Liu
Postdoctoral Scholar, Epidemiology
BioLili (Larry) Liu, PhD, is a postdoctoral fellow in the Department of Epidemiology and Population Health at Stanford University. Dr. Liu is an integrative epidemiologist whose research is unified by a consistent methodological approach rather than a single disease area. Across his master’s, doctoral, and postdoctoral training, he has repeatedly developed or operationalized epidemiologic frameworks and analytic programs and applied them to important public health questions spanning rare diseases, chronic disease, cancer, mortality, microbiome, and women’s health. His work brings together molecular biomarkers, large-scale population cohorts, and real-world health data to generate coherent, hypothesis-driven research on how genetic variation, lifestyle, pharmacologic factors, and early-life exposures shape inflammation, biological aging, and chronic disease risk across the life course.
During his master’s training at Peking University, Dr. Liu developed expertise in literature synthesis, national claims-based study, rare disease burden estimation, patient-centered health information research, cohort-based analysis, and vaccine effectiveness evaluation. He helped build and apply claims-based analytic algorithms to estimate incidence and prevalence for multiple rare diseases in China, led first-author studies on online health information and patient information needs in rare disease populations, and established an analytic framework for CHARLS-based cohort studies that supported multiple downstream projects. During his PhD training at Vanderbilt University, he expanded into population genetics, molecular and cancer epidemiology, mortality and health disparities research, gut microbiome, and pooled multi-study analyses. His doctoral work included a multi-ancestry GWAS of urinary prostaglandin E2 metabolite (PGE-M), development of PGE-M-derived dietary and lifestyle scores, and Mendelian randomization analyses linking lipid-related pathways to colorectal cancer risk. He also led several first-author studies in the Southern Community Cohort Study on poverty, sitting time, physical activity, walking and mortality, and alcohol intake and the gut microbiome, several of which received substantial public health and media attention.
At Stanford, Dr. Liu has developed an independent research program centered on women’s health and life-course epidemiology using U.S. national claims data. He has built large nationwide pregnancy and mother-baby cohorts from MarketScan to study adverse obstetric outcomes, long-term cardiometabolic and hepatic outcomes, and early-onset cancer risk. His first corresponding-author paper at Stanford examined gestational diabetes in relation to subsequent type 2 diabetes and metabolic dysfunction-associated steatotic liver disease, and his ongoing work extends this framework to cardiovascular, kidney, metabolic, and reproductive health outcomes, including PCOS and endometriosis. He also received a Stanford MCHRI fellowship grant to study prenatal and early-life antibiotic exposure in relation to pediatric inflammatory bowel disease and celiac disease. In parallel, his collaborative work includes placental and maternal-fetal research on extracellular vesicles and angiogenic signaling.
Methodologically, Dr. Liu works at the interface of causal inference, pharmacoepidemiology, molecular epidemiology, and scalable real-world data science, using reproducible analytic pipelines in R, Python, SQL, and high-performance computing environments. Across all stages of his training, the central theme of his work has been to build scalable analytic infrastructure and apply it to high-impact epidemiologic questions with broad public health relevance, with the overarching goal of translating rigorous population science into actionable strategies for chronic disease prevention in diverse populations. -
Lianli Liu
Clinical Assistant Professor, Radiation Oncology - Radiation Physics
Current Research and Scholarly InterestsAI-driven medical imaging for accelerated imaging speed and improved image quality, including:
Accelerated imaging for in-treatment patient monitoring and post-treatment patient follow up;
Functional imaging for treatment response evaluation and prediction.
Optimizing clinical quality assurance workflow through AI, including:
Radiation beam data modeling for efficient commissioning;
Model-based error detection for accurate dosimetry. -
Lin Liu
Postdoctoral Scholar, Chemistry
BioI finished my undergraduate study in general chemistry at Shandong Normal University in 2014. Later, I continued to my master’s studies in organic chemistry at Lanzhou University. In 2018, I moved to Baylor University conducting research under the mentorship of Professor John L. Wood. During my graduate studies, I mainly focused on the total syntheses of natural products. In 2024, I joined the Khosla lab and Cui lab as a joint postdoc. Outside the lab, I like cooking, playing basketball, and watching movies
